The big biotech fund is loaded with a value that rose in 2024 and a loser
Source link
The debts of EY’s failed Project Everest are taking longer than expected to clear
Unlock Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories in this weekly newsletter. EY is taking longer than originally planned to clear the debts…